SCHEMBL2140832

SCHEMBL2140832

CCCCCCCCCCCC/C=C/C=C/CCCCCCCCC(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FASN P49327 1/20 1.00
PPARG P37231 5/20 0.85
PPARD Q03181 5/20 0.85
PPARA Q07869 5/20 0.85
F7 P08709 5/20 0.85
F3 P13726 5/20 0.85
TERT O14746 3/20 0.85
PTPN1 P18031 3/20 0.85
HSD17B10 Q99714 3/20 0.85
FABP4 P15090 3/20 0.85
MAPT P10636 2/20 0.85
BLM P54132 2/20 0.85
LMNA P02545 2/20 0.85
ALOX15 P16050 2/20 0.85
DUSP3 P51452 2/20 0.85
CYP19A1 P11511 2/20 0.85
PTGS1 P23219 2/20 0.85
NR4A2 P43354 2/20 0.85
SIRT6 Q8N6T7 2/20 0.85
PTPN7 P35236 2/20 0.85

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1870861 1.00 FASN (1.00) FASNPPARGPPARDPPARAF7
SCHEMBL635133 1.00 FASN (1.00) FASNPPARGPPARDPPARAF7
SCHEMBL1878113 1.00 FASN (1.00) FASNPPARGPPARDPPARAF7
SCHEMBL19529657 1.00 FASN (1.00) FASNPPARGPPARDPPARAF7
SCHEMBL3953180 1.00 FASN (1.00) FASNPPARGPPARDPPARAF7
SCHEMBL3952605 1.00 FASN (1.00) FASNPPARGPPARDPPARAF7
SCHEMBL288695 1.00 FASN (1.00) FASNPPARGPPARDPPARAF7
SCHEMBL3201525 1.00 FASN (1.00) FASNPPARGPPARDPPARAF7
SCHEMBL20514850 1.00 FASN (1.00) FASNPPARGPPARDPPARAF7
SCHEMBL4732554 1.00 FASN (1.00) FASNPPARGPPARDPPARAF7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2991627-B1 BLOOD SUBSTITUTE COMPOSITION AND METHOD OF USE UNIV WASHINGTON (US) 2018-09-05 EP claimed
WO-2023229391-A1 LEAD ION-DETECTING COMPOSITION CONTAINING POLYDIACETYLENE LIPOSOME, PREPARATION METHOD THEREFOR, AND LEAD ION DETECTION METHOD 인제대학교 산학협력단 2023-11-30 WO disclosed
US-11008658-B2 Controlled growth of ultranarrow nanowires on functionalized 2D materials PURDUE RESEARCH FOUNDATION (US) 2021-05-18 US disclosed
US-20210039286-A1 Dip-Molded Article, Latex Composition for Dip-Molding and Preparation Method Thereof LG CHEM, LTD. (KR) 2021-02-11 US disclosed
EP-3722355-A1 DIP MOLDED PRODUCT, LATEX COMPOSITION FOR DIP MOLDING, AND PREPARATION METHODS THEREFOR LG Chem, Ltd. (KR) 2020-10-14 EP disclosed
US-20190264332-A1 CONTROLLED GROWTH OF ULTRANARROW NANOWIRES ON FUNCTIONALIZED 2D MATERIALS AND USES THEREOF PURDUE RESEARCH FOUNDATION (US) 2019-08-29 US disclosed
WO-2019112306-A1 DIP MOLDED PRODUCT, LATEX COMPOSITION FOR DIP MOLDING, AND PREPARATION METHODS THEREFOR 주식회사 엘지화학 2019-06-13 WO disclosed
US-9683006-B2 Method of purifying/concentrating sugar chains with a sugar chain-trapping molecule and method of analyzing sugar chain structure SUMITOMO BAKELITE CO., LTD. (JP) 2017-06-20 US disclosed
US-9139607-B2 Method of purifying/concentrating sugar chain with sugar chain-trapping molecule and method of analyzing sugar chain structure SUMITOMO BAKELITE CO., LTD. (JP) 2015-09-22 US disclosed
US-20150175652-A1 METHOD OF PURIFYING/CONCENTRATING SUGAR CHAINS WITH A SUGAR CHAIN-TRAPPING MOLECULE AND METHOD OF ANALYZING SUGAR CHAIN STRUCTURE SUMITOMO BAKELITE CO (JP) 2015-06-25 US disclosed
EP-1577293-B1 METHOD OF PURIFYING/CONCENTRATING SUGAR CHAIN WITH SUGAR CHAIN-TRAPPING MOLECULE AND METHOD OF ANALYZING SUGAR CHAIN STRUCTURE SHIONOGI & CO (JP) 2014-06-18 EP disclosed
EP-2444408-A2 METHOD OF PURIFYING/CONCENTRATING SUGAR CHAIN WITH SUGAR CHAIN-TRAPPING MOLECULE AND METHOD OF ANALYZING SUGAR CHAIN STRUCTURE Shionogi&Co., Ltd. (JP) 2012-04-25 EP disclosed
US-20060188996-A1 Method of purifying/concentrating sugar chain with sugar chain-trapping molecule and mehtod of analyzing sugar chain structure SHIONOGI CO., LTD. (JP) 2006-08-24 US disclosed
EP-1577293-A1 METHOD OF PURIFYING/CONCENTRATING SUGAR CHAIN WITH SUGAR CHAIN-TRAPPING MOLECULE AND METHOD OF ANALYZING SUGAR CHAIN STRUCTURE Shionogi Co., Ltd. (JP) 2005-09-21 EP disclosed
US-5139913-A High sensitivity, high ratio of light current to dark current and fast optical response FUJI XEROX CO., LTD. (JP) 1992-08-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150175652-A1 METHOD OF PURIFYING/CONCENTRATING SUGAR CHAINS WITH A SUGAR CHAIN-TRAPPING MOLECULE AND METHOD OF ANALYZING SUGAR CHAIN STRUCTURE SLC2A2, SLC2A1, SLC2A4 FASN 2190/4885PPARG 4202/4885PPARD 4647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.